NK
Kiyota N
Kobe University Hospital, National Cancer Center Hospital East, Kobe University, Saiseikai Nakatsu Hospital
Research areas: Medicine · Otorhinolaryngology · Head and Neck Cancer Studies · Head and Neck Surgical Oncology · Cancer Immunotherapy and Biomarkers
0000-0001-8021-6116
Employment
-
Kobe University Hospital Associate Professor2017 - Present
-
Kobe University Hospital Assistant Professor2008 - 2017
- 2005 - 2008
- 1999 - 2005
Education
- 1993 - 1999
Projects & Funding
-
National Cancer Center Research and Development Funds National Cancer Center2022 - 2023
-
AMED Japan Agency for Medical Research and Development2022 - 2023
Publications (182)
- Score interpretation thresholds for the European Organisation for Research and Treatment of Cancer thyroid cancer quality of life questionnaire (EORTC QLQ-THY34). An international prospective study Save
- Current status and future perspectives of treatment de-escalation in localized head and neck cancer Save
- Encorafenib plus binimetinib for BRAF V600-mutated thyroid cancer in Japan: final analysis Save
- Long-Term Follow-Up of JCOG1008, a Randomized Phase II/III Trial of Chemoradiotherapy Comparing 3-Weekly Cisplatin With Weekly Cisplatin in Postoperative Head and Neck Cancer Save
- Risk factors for aspiration pneumonia related to postoperative chemoradiotherapy for high-risk head and neck cancer: A supplementary analysis of a phase II/III JCOG1008 trial Save
- Health-related quality of life with encorafenib plus binimetinib for BRAFV600E thyroid cancer Save
- A phase II trial of nivolumab for patients with platinum-refractory recurrent or metastatic salivary gland cancer Save
- Neoadjuvant FOLFOXIRI plus bevacizumab without radiotherapy for high-risk rectal cancer: multicentre phase II trial Save
- Adverse event profiles and management of cisplatin-based chemoradiotherapy in locally advanced head and neck squamous cell carcinoma: a systematic review Save
- Caution Needed Before Adopting Reduced-Dose Elective Neck Irradiation in Head and Neck Cancer: A Response to UPGRADE-RT Save
- Multicenter phase II trial of trastuzumab and docetaxel for HER2-positive salivary gland cancer Save
- Multicenter, open-label, randomized, controlled study to test the utility of electronic patient-reported outcome monitoring in patients with unresectable advanced cancers or metastatic/recurrent solid tumors Save
- Anticancer drug therapy for anaplastic thyroid cancer Save
- A Phase 2 Study of Encorafenib in Combination with Binimetinib in Patients with Metastatic BRAF-Mutated Thyroid Cancer in Japan ( vol 34 , pg 467 , 2024) Save
- Dose-Dependent Occurrence of Nasolacrimal Duct Obstruction and Eye Watering after Radiation Therapy for Nasal/Paranasal Malignant Tumors Save
- Retrospective study of definitive therapy for head and neck mucosal melanoma: The RESUME study Save
- The 2024 revised clinical guidelines on the management of thyroid tumors by the Japan Association of Endocrine Surgery Save
- Effect of acute kidney injury and overall survival in patients with postoperative head and neck cancer who received chemoradiotherapy with cisplatin: A supplementary analysis of the phase II/III trial of JCOG1008 Save
- Risk prediction model for cisplatin-induced acute kidney injury in patients with head and neck cancer receiving chemoradiotherapy: A re-analysis of a phase II/III JCOG1008 trial Save
- Current status and future perspective of postoperative treatment for locally advanced squamous cell carcinoma of the head and neck Save